Svas Biosana S.p.A. (BIT:SVS)
8.30
+0.08 (0.97%)
At close: Sep 26, 2025
Svas Biosana Revenue
Svas Biosana had revenue of 63.25M EUR in the half year ending December 31, 2024, with 15.37% growth. This brings the company's revenue in the last twelve months to 134.91M, up 8.95% year-over-year. In the year 2024, Svas Biosana had annual revenue of 122.29M with 0.54% growth.
Revenue (ttm)
134.91M
Revenue Growth
+8.95%
P/S Ratio
0.33
Revenue / Employee
412.57K
Employees
327
Market Cap
44.10M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 122.29M | 656.90K | 0.54% |
Dec 31, 2023 | 121.63M | 22.12M | 22.22% |
Dec 31, 2022 | 99.51M | 17.52M | 21.37% |
Dec 31, 2021 | 81.99M | 4.72M | 6.11% |
Dec 31, 2020 | 77.27M | -23.22M | -23.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.48B |
DiaSorin | 1.22B |
Amplifon | 2.41B |
Philogen | 84.66M |
EL.En. | 579.71M |
Safilo Group | 998.89M |
GPI S.p.A. | 509.93M |
Garofalo Health Care | 474.78M |